Little genomic support for cyclophilin A-matrix metalloproteinase-9 pathway as a therapeutic target for cognitive impairment in APOE4 carriers (2021)
Attributed to:
Physiological resilience: mechanisms and consequences
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.04.22.21255729
Publication URI: http://dx.doi.org/10.1101/2021.04.22.21255729
Type: Preprint